Skip to main content
Top
Published in: Journal of Clinical Immunology 2/2010

01-03-2010

Leukocyte Adhesion Deficiency Type II: Long-Term Follow-Up and Review of the Literature

Authors: Yael Gazit, Adi Mory, Amos Etzioni, Moshe Frydman, Oded Scheuerman, Ruth Gershoni-Baruch, Ben-Zion Garty

Published in: Journal of Clinical Immunology | Issue 2/2010

Login to get access

Abstract

Introduction

Leukocyte adhesion deficiency (LAD) is a group of rare inherited disorders characterized by immune deficiency and peripheral neutrophilia. There are only seven reported cases of LAD type II worldwide, and no long-term follow-up data.

Case Report

We reviewed the medical file of a 20-year-old man with LAD II. Clinical characteristics included short stature, severe mental retardation, and autistic features. He had had no severe infections since infancy, and his current immunological status was stable. The last laboratory work-up revealed mild leukocytosis and neutrophilia. Genetic analysis of the Golgi GDP-fucose transporter (GFTP) sequence yielded a point mutation resulting in Y337C amino acid transition in the tenth transmembrane domain.

Conclusion

In conclusion, in LAD II, the main clinical countenance shifts from frequent infections due to immunodeficiency in the early years to the metabolic consequences of the defect in fucose metabolism, i.e., retarded growth and mental retardation, in the later years. A novel mutation in the GFTP loci associated with LAD II is described.
Literature
1.
go back to reference Anderson DC, Smith CW. Leukocyte adhesion deficiencies. In: Scriver C, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited diseases. 8th ed. New York: McGraw-Hill; 2001. p. 4829–56. Anderson DC, Smith CW. Leukocyte adhesion deficiencies. In: Scriver C, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited diseases. 8th ed. New York: McGraw-Hill; 2001. p. 4829–56.
2.
go back to reference Bauer TR, Allen JM, Hai M, Tuschong LM, Khan IF, Olson EM, et al. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vector. Nat Med. 2008;14:93–7.CrossRefPubMed Bauer TR, Allen JM, Hai M, Tuschong LM, Khan IF, Olson EM, et al. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vector. Nat Med. 2008;14:93–7.CrossRefPubMed
3.
go back to reference Yakubenia S, Wild MK. Leukocyte adhesion deficiency II advances and open questions. FEBS J. 2006;273:4390–8.CrossRefPubMed Yakubenia S, Wild MK. Leukocyte adhesion deficiency II advances and open questions. FEBS J. 2006;273:4390–8.CrossRefPubMed
4.
go back to reference Marquardt T, Lühn K, Srikrishna G, Freeze HH, Harms E, Vestweber D. Correction of leukocyte adhesion deficiency type II with oral fucose. Blood. 1999;94:3976–85.PubMed Marquardt T, Lühn K, Srikrishna G, Freeze HH, Harms E, Vestweber D. Correction of leukocyte adhesion deficiency type II with oral fucose. Blood. 1999;94:3976–85.PubMed
5.
go back to reference Etzioni A, Tonetti M, Vestweber D, Marquardt T. Fucose supplementation in leukocyte adhesion deficiency type II. Blood. 2000;95:3641–3.PubMed Etzioni A, Tonetti M, Vestweber D, Marquardt T. Fucose supplementation in leukocyte adhesion deficiency type II. Blood. 2000;95:3641–3.PubMed
6.
go back to reference Alon R, Etioni A. LAD III, a novel group of leukocyte integrin activation deficiencies. Trends Immunol. 2003;24:561–6.CrossRefPubMed Alon R, Etioni A. LAD III, a novel group of leukocyte integrin activation deficiencies. Trends Immunol. 2003;24:561–6.CrossRefPubMed
7.
go back to reference Mory A, Feigelson SW, Yarali N, Kilic SS, Bayhon GI, Gershoni-Baruch R. Kindlin-3: a new gene involved in the pathogenesis of LAD III. Blood. 2008;112:2591.CrossRefPubMed Mory A, Feigelson SW, Yarali N, Kilic SS, Bayhon GI, Gershoni-Baruch R. Kindlin-3: a new gene involved in the pathogenesis of LAD III. Blood. 2008;112:2591.CrossRefPubMed
8.
go back to reference Svensson L, Howarth K, McDowall A, Patzak I, Evans R, Ussar S, et al. Leukocyte adhesion deficiency III is caused by mutations in Kindlin3 affecting integrin activation. Nat Med. 2009;15:306–12.CrossRefPubMed Svensson L, Howarth K, McDowall A, Patzak I, Evans R, Ussar S, et al. Leukocyte adhesion deficiency III is caused by mutations in Kindlin3 affecting integrin activation. Nat Med. 2009;15:306–12.CrossRefPubMed
9.
go back to reference Etzioni A, Frydman M, Pollack S, Avidor I, Phillips ML, Paulson JR, et al. Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med. 1992;327(25):1789–92.PubMedCrossRef Etzioni A, Frydman M, Pollack S, Avidor I, Phillips ML, Paulson JR, et al. Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med. 1992;327(25):1789–92.PubMedCrossRef
10.
go back to reference Frydman M, Etzioni A, Eidlitz-Markus T, Avidor I, Varsano I, Shechter Y, et al. Rambam–Hasharon syndrome of psychomotor retardation, short stature, defective neutrophil motility, and Bombay phenotype. Am J Med Genet. 1992;44:297–302.CrossRefPubMed Frydman M, Etzioni A, Eidlitz-Markus T, Avidor I, Varsano I, Shechter Y, et al. Rambam–Hasharon syndrome of psychomotor retardation, short stature, defective neutrophil motility, and Bombay phenotype. Am J Med Genet. 1992;44:297–302.CrossRefPubMed
11.
go back to reference Etzioni A, Sturla L, Antonellis A, Green ED, Gershoni-Baruch R, Berninsone PM, et al. Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG)IIc founder effect and genotype/phenotype correlation. Am J Med Genet. 2002;110:131–5.CrossRefPubMed Etzioni A, Sturla L, Antonellis A, Green ED, Gershoni-Baruch R, Berninsone PM, et al. Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG)IIc founder effect and genotype/phenotype correlation. Am J Med Genet. 2002;110:131–5.CrossRefPubMed
12.
go back to reference Marquardt T, Brune T, Lühn K, Zimmer KP, Korner C, Fahntz L, et al. Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism. J Pediatr. 1999;134:681–8.CrossRefPubMed Marquardt T, Brune T, Lühn K, Zimmer KP, Korner C, Fahntz L, et al. Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism. J Pediatr. 1999;134:681–8.CrossRefPubMed
13.
go back to reference Hidalgo A, Ma S, Peired AJ, Weiss LA, Cunningham-Rundles C, Frenette PS. Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene. Blood. 2003;101:1705–12.CrossRefPubMed Hidalgo A, Ma S, Peired AJ, Weiss LA, Cunningham-Rundles C, Frenette PS. Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene. Blood. 2003;101:1705–12.CrossRefPubMed
14.
go back to reference Helmus Y, Denecke J, Yakubenia S, Robinson P, Luhn K, Watson DL, et al. Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter. Blood. 2006;107:3959–66.CrossRefPubMed Helmus Y, Denecke J, Yakubenia S, Robinson P, Luhn K, Watson DL, et al. Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter. Blood. 2006;107:3959–66.CrossRefPubMed
15.
go back to reference Etzioni A, Gershoni-Baruch R, Pollack S, Shehadeh N. Leukocyte adhesion deficiency type II: long-term follow-up. J Allergy Clin Immunol. 1998;102:323–4.CrossRefPubMed Etzioni A, Gershoni-Baruch R, Pollack S, Shehadeh N. Leukocyte adhesion deficiency type II: long-term follow-up. J Allergy Clin Immunol. 1998;102:323–4.CrossRefPubMed
16.
go back to reference Frydman M, Vardimon D, Shalev E, Orlin JB. Prenatal diagnosis of Rambam–Hasharon syndrome. Prenat Diagn. 1996;16:266–9.CrossRefPubMed Frydman M, Vardimon D, Shalev E, Orlin JB. Prenatal diagnosis of Rambam–Hasharon syndrome. Prenat Diagn. 1996;16:266–9.CrossRefPubMed
17.
go back to reference Wild MK, Lühn K, Marquardt T, Vestweber D. Leukocyte adhesion deficiency II: therapy and genetic defect. Cells Tissues Organs. 2002;172:161–73.CrossRefPubMed Wild MK, Lühn K, Marquardt T, Vestweber D. Leukocyte adhesion deficiency II: therapy and genetic defect. Cells Tissues Organs. 2002;172:161–73.CrossRefPubMed
18.
go back to reference Lühn K, Marquardt T, Harm E, Vestweber D. Discontinuation of fucose therapy in LAD II causes rapid loss of selectin ligands and rise of leukocyte counts. Blood. 2001;97:330–2.CrossRefPubMed Lühn K, Marquardt T, Harm E, Vestweber D. Discontinuation of fucose therapy in LAD II causes rapid loss of selectin ligands and rise of leukocyte counts. Blood. 2001;97:330–2.CrossRefPubMed
19.
go back to reference Sturla L, Puglielli L, Tonetti M, Berninsone P, Hirschberg CB, De Fiora A, et al. Impairment of the Golgi GDP-L-fucose transport and unresponsiveness to fucose replacement therapy in LAD II patients. Pediatr Res. 2001;49(4):537–42.CrossRefPubMed Sturla L, Puglielli L, Tonetti M, Berninsone P, Hirschberg CB, De Fiora A, et al. Impairment of the Golgi GDP-L-fucose transport and unresponsiveness to fucose replacement therapy in LAD II patients. Pediatr Res. 2001;49(4):537–42.CrossRefPubMed
20.
go back to reference Aebi M, Helenius A, Schenk B, Barone R, Fiumara A, Berger EG, et al. Carbohydrate deficient glycoprotein syndrome becomes congenital disorder of glycosylation: an updated nomenclature for CDG. First International Workshop on CDGS. Glycoconj J. 1999;16:669–71.CrossRefPubMed Aebi M, Helenius A, Schenk B, Barone R, Fiumara A, Berger EG, et al. Carbohydrate deficient glycoprotein syndrome becomes congenital disorder of glycosylation: an updated nomenclature for CDG. First International Workshop on CDGS. Glycoconj J. 1999;16:669–71.CrossRefPubMed
21.
go back to reference Lübke T, Marquardt T, Etzioni A, Hartmann E, von Figura K, Körner C. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat Genet. 2001;28:73–6.CrossRefPubMed Lübke T, Marquardt T, Etzioni A, Hartmann E, von Figura K, Körner C. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency. Nat Genet. 2001;28:73–6.CrossRefPubMed
22.
go back to reference Lühn K, Wild MD, Gerardy-Schahn R, Vestweber D. The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter. Nat Genet. 2001;28:69–72.CrossRefPubMed Lühn K, Wild MD, Gerardy-Schahn R, Vestweber D. The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter. Nat Genet. 2001;28:69–72.CrossRefPubMed
Metadata
Title
Leukocyte Adhesion Deficiency Type II: Long-Term Follow-Up and Review of the Literature
Authors
Yael Gazit
Adi Mory
Amos Etzioni
Moshe Frydman
Oded Scheuerman
Ruth Gershoni-Baruch
Ben-Zion Garty
Publication date
01-03-2010
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 2/2010
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-009-9354-0

Other articles of this Issue 2/2010

Journal of Clinical Immunology 2/2010 Go to the issue